Skip to content

Clinical trials

Recruiting Pancreatic Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Recruiting Country / region: Australia Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20191
20202
20211
20222
20231
20245
202511
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Verastem, Inc.2
Apollomics Inc.1
Arbor Research Collaborative for Health1
AstraZeneca1
Bayer1
Bicara Therapeutics1
BioNTech SE1
Cambridge University Hospitals NHS Foundation Trust1
Daiichi Sankyo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms29
Breast Neoplasms13
Ovarian Neoplasms12
Endometrial Neoplasms10
Prostatic Neoplasms10
Colorectal Neoplasms9
Lung Neoplasms8
Neoplasm Metastasis8
Carcinoma, Non-Small-Cell Lung7
Stomach Neoplasms7

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.